Abstract
AbstractBackgroundAntimicrobial resistance (AMR) in Neisseria gonorrhoeae is a continuing global health challenge. Limitations to current national surveillance systems for reporting AMR trends, alongside reduction in culture-based diagnostics and susceptibility testing, has led to an increasing need for rapid diagnostics and identification of circulating N. gonorrhoeae strains. We investigated nanopore based sequencing time and depth needed to accurately identify closely related N. gonorrhoeae isolates, compared to Illumina MiSeq sequencing.MethodsN. gonorrhoeae strains prospectively collected from a London Sexual Health clinic were sequenced on both Illumina MiSeq and Oxford Nanopore Technologies (ONT) MinION platforms. Accuracy was determined by comparing variant calls at 68 nucleotide positions representing 37 pre-characterised resistance associated markers in N. gonorrhoeae. Accuracy at varying MinION sequencing depths were determined through retrospective analysis of time-stamped reads.ResultsOf the 22 MinION-MiSeq sequence pairs that reached sufficient depth of coverage for comparison, overall agreement of variant call positions passing quality control criteria was 185/185 (95% CI: 98.0-100.0), 502/503 (95% CI: 98.9-99.9) and 564/565 (95% CI: 99.0-100.0) at 10x, 30x and 40x MinION depth, respectively. Isolates found to be genetically closely related by MiSeq, that is within one yearly evolutionary distance of ≤5 single nucleotide polymorphisms, were accurately identified as such via MinION.ConclusionNanopore based sequencing shows utility for use as a rapid surveillance tool to correctly detect closely related N. gonorrhoeae strains, with just 10x sequencing depth, taking a median sequencing time of 29 minutes. This highlights its potential utility for tracking local gonorrhoea transmission and AMR markers.
Publisher
Cold Spring Harbor Laboratory
Reference39 articles.
1. Unemo M , Lahra MM , Cole M , et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health 2019: 412–25.
2. Unemo M , Seifert HS , Hook EW , Hawkes S , Ndowa F , Dillon JAR . Gonorrhoea. Nature Reviews Disease Primers 2019; 5.
3. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae: World Health Organization, 2012.
4. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action;PLOS Medicine,2017
5. UK Health Security Agency. Surveillance of antimicrobial resistance in Neisseria gonorrhoeae in England and Wales Key findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP), 2020.